Immunological profile in primary Sjögren syndrome. Clinical significance, prognosis and long-term evolution to other auto-immune disease.

Autoimmunity Reviews

Volumn 9, Issue 9, 2010, Pages 595-599

  Fauchais, A L ^a   Martel, C ^a   Gondran, G ^a   Lambert, M ^b   Launay, D ^b   Jauberteau, M O ^a   Hachulla, E ^b   Vidal, E ^a   Hatron, P Y ^b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Anti SSA SSB antibodies; Cryoglobulinemia; Lupus erythematosus; Polymyositis; Primary Sj gren's syndrome; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; DNA ANTIBODY; HISTONE ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY;

ADULT; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PROGNOSIS; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMYOSITIS; PROGNOSIS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 77954385282     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.004     Document Type: Review

References (35)

1. Fox R.I., Stern M., Michelson P. Update in Sjögren syndrome. Curr Opin Rheumatol 2000, 12:391-398.
2. Alexander E., Arnett F., Provost T. Sjögren's syndrome: association of anti-SSA antibodies with vasculitis, immunologic abnormalities and serologic hyperactivity. Ann Med Int 1983, 98:155-159.
3. Pease C.T., Shattles W., Charles P.J., Venables P.J., Maini R.N. Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome. Clin Exp Rheumatol 1989, 7:185-190.
4. Kelly C.A., Foster H., Pal B., Gardiner P., Malcolm A.J., Charles P., et al. Primary Sjögren's syndrome in North East England-a longitudinal study. Br J Rheumatol 1991, 30:437-442.
5. Cho C.S., Park S.H., Min J.K., Lee S.H., Kim H.Y. Clinical significances of antibodies to SSA autoantigens and its subtypes in primary Sjögren's syndrome. Korean J Intern Med 1997, 12:176-181.
6. Davidson B.K., Kelly C.A., Griffiths I.D. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) 1999, 38:245-253.
7. Mavragani C.P., Tzioufas A.G., Moutsopoulos H.M. Sjögren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects. Int Arch Allergy Immunol 2000, 123:46-57.
8. Garcia-Carrasco M., Ramos-Casals M., Rosas J., Pallares L., Calvo-Alen J., Cervera R., et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002, 81:270-280.
9. Ramos-Casals M., Font J., Garcia-Carrasco M., Brito M.P., Rosas J., Calvo-Alen J., et al. Primary Sjögren syndrome: hematologic patterns of disease expression. Medicine (Baltimore) 2002, 81:281-292.
10. Ramos-Casals M., Anaya J.M., Garcia-Carrasco M., Rosas J., Bove A., Claver G., et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004, 83:96-106.
11. Fauchais A.L., Lambert M., Dubucquoi S., Hachulla E., Pasturel U., Queyrel V., et al. Inaugural Raynaud's phenomenon is associated with a multisystemic involvement during follow up in primary Sjögren syndrome - a report of 162 patients. Int J Angiol 2004, 13:1061-1711.
12. Fauchais AL, Ouattara B, Gondran G, Lalloué F, Petit D, Ly K, et al. Articular manifestations in primary Sjögren syndrome clinical significance and prognosis of 188 patients. Rheumatology (Oxford) in press.
13. Muller K., Oxholm P., Mier-Madsen M., Wiik A. Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations. Scand J Rheumatol 1989, 18:29-31.
14. Ramos-Casals M., Solans R., Rosas J., Camps M.T., Gil A., Del Pino-Montes J., et al. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 2008, 87:210-219.
15. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88:284-293.
16. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002, 46:741-747.
17. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L.T. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006, 65:796-803.
18. Brito-Zeron P., Ramos-Casals M., Bove A., Sentis J., Font J. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology (Oxford) 2007, 46:1359-1362.
19. Locht H., Pelck R., Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev 2005, 4:276-281.
20. Whaley K., Webb J., McAvoy B.A., Hughes G.R., Lee P., MacSween R.N., et al. Sjögren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med 1973, 42:513-548.
21. Manthorpe R., Frost-Larsen K., Isager H., Prause J.U. Sjögren's syndrome. A review with emphasis on immunological features. Allergy 1981, 36:139-153.
22. Manoussakis M.N., Tzioufas A.G., Pange P.J., Moutsopoulos H.M. Serological profiles in subgroups of patients with Sjögren's syndrome. Scand J Rheumatol Suppl 1986, 61:89-92.
23. Nardi N., Brito-Zeron P., Ramos-Casals M., Aguilo S., Cervera R., Ingelmo M., et al. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol 2006, 25:341-346.
24. Horvath I.F., Szodoray P., Zeher M. Primary Sjögren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 2008, 27:1479-1483.
25. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002, 61:554-558.
26. Gondran G., Fauchais AL., Lambert M., Ly K., Launay D., Queyrel V., et al. Primary Sjögren's syndrome in men. Scand J Rheumatol 2008, 37:300-305.
27. Cui G., Sugai S., Ogawa Y., Takeshita S., Masaki Y., Fukutoku M. Long-term follow-up of 43 patients with Sjögren's syndrome. Ryumachi 1997, 37:770-780.
28. Tzioufas A.G., Boumba D.S., Skopouli F.N., Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996, 39:767-772.
29. Kruize A.A., Hené R.J., van der Heide A., Bodeutsch C., de Wilde P.C., van Bijsterveld O.P., et al. Long-term follow-up of patients with Sjögren's syndrome. Arthritis Rheum 1996, 39:297-303.
30. Zufferey P., Meyer O.C., Grossin M., Kahn M.F. Primary Sjögren's syndrome and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995, 24:342-345.
31. Asmussen K., Andersen V., Bendixen G., Schiodt M., Oxholm P. A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study. J Intern Med 1996, 239:475-482.
32. Markusse H.M., Oudkerk M., Vroom T.M., Breedveld F.C. Primary Sjögren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology. Neth J Med 1992, 40:125-134.
33. Satoh M., Yamagata H., Watanabe F., Nakayama S., Ogasawara T., Tojo T., et al. Development of anti-sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjögren's syndrome. Lupus 1995, 4:63-65.
34. Zufferey P., Meyer O.C., Bourgeois P., Vayssairat M., Kahn M.F. Primary systemic Sjögren syndrome preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 Sjögren's patients. Lupus 1995, 4:23-27.
35. Lazarus M.N., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome. Ann Rheum Dis 2005, 64:1062-1064.